Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia ... has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth.

MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...

Brukinsa had a lower risk of disease progression or death versus Imbruvica, as well as a more favorable safety profile, in R/R CLL and SLL.

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

Leukemia is classified by stage. Different types of leukemia (acute vs. chronic) have different staging systems—with some with as few as three stages and others with as many as seven—but each ...

A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...

TBI remained significantly associated with reduced adjusted risks of grade 3 to 4 aGVHD and moderate-severe cGVHD.

THIS boy was given a second chance at life by his sister, who fought through sepsis to help him survive. Three-year-old James Gillespie, the youngest of six children, was rushed to hospital on ...

Myeloid leukemias are called: Acute myeloid leukemia (AML) Chronic myeloid leukemia (CML) The word "myeloid" also refers to a group of cells that differentiate, or mature, from a common myeloid ...

Notably, Deborah E. Banker’s 2004 article, “Cholesterol synthesis and import contribute to protective cholesterol increases in acute myeloid leukemia cells” (2006-2009, intensity 7.54), presented the ...